Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery

References

• ToddPAFauldsDOfloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic useDrugs19914258258761723377
   PubMed Web of Science ®Google Scholar
• LudwigEControversies on pharmacokinetics of fluoroquinolones in elderly patientsInt J Antimicrob Agents199331495918611544
   PubMedGoogle Scholar
• HummaLMPrevention and treatment of drug-resistant tuberculosisAm J Health Syst Pharm1996531922912298 quiz 23358893067
   PubMed Web of Science ®Google Scholar
• AlangadenGJLernerSAThe clinical use of fluoroquinolones for the treatment of mycobacterial diseasesClin Infect Dis1997255121312219402384
   PubMed Web of Science ®Google Scholar
• KawaharaSTadaANagareHClinical evaluation of new quinolones as antituberculosis drugsKekkaku19997417175 Japanese10067058
   PubMedGoogle Scholar
• GoslingRDUisoLOSamNEThe bactericidal activity of moxifloxacin in patients with pulmonary tuberculosisAm J Respir Crit Care Med2003168111342134512917230
   PubMed Web of Science ®Google Scholar
• MansourHMRheeYSWuXNanomedicine in pulmonary deliveryInt J Nanomedicine2009429931920054434
   PubMed Web of Science ®Google Scholar
• SongJHWhat’s new on the antimicrobial horizon?Int J Antimicrob Agents200832Suppl 4S207S21319134521
   PubMed Web of Science ®Google Scholar
• Garcia-ContrerasLHickeyAJPharmaceutical and biotechnological aerosols for cystic fibrosis therapyAdv Drug Deliv Rev200254111491150412458157
   PubMed Web of Science ®Google Scholar
• MansourHMRheeYSParkCWDeLucaPPLipid nanoparticulate drug delivery and nanomedicineMoghisALipids in Nanotechnology1st edUrbana, ILAmerican Oil Chemists Society (AOCS) Press2011221268
   Google Scholar
• HayesDJrMurphyBSMullettTWFeolaDJAerosolized vancomycin for the treatment of MRSA after lung transplantationRespirology201015118418619895389
   PubMed Web of Science ®Google Scholar
• PisonUWelteTGiersigMGronebergDANanomedicine for respiratory diseasesEur J Pharmacol20065331–334135016434033
   PubMed Web of Science ®Google Scholar
• KurmiBDKayatJGajbhiyeVTekadeRKJainNKMicro- and nanocarrier-mediated lung targetingExpert Opin Drug Deliv20107778179420560777
   PubMed Web of Science ®Google Scholar
• ParkCWHayesDJrMansourHMPulmonary inhalation aerosols for targeted antibiotics drug deliveryEuropean Pharmaceutical Review20111613236
   Google Scholar
• GilbertBELiposomal aerosols in the management of pulmonary infectionsJ Aerosol Med19969111112210160201
   PubMedGoogle Scholar
• OkusanyaOOBhavnaniSMHammelJPharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infectionAntimicrob Agents Chemother20095393847385419451281
   PubMed Web of Science ®Google Scholar
• WeersJMetzheiserBTaylorGWarrenSMeersPPerkinsWRA gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteersJ Aerosol Med Pulm Drug Deliv200922213113819422313
   PubMed Web of Science ®Google Scholar
• WillisLHayesDJrMansourHMTherapeutic liposomal dry powder inhalation aerosols for targeted lung deliveryLung2012190325126222274758
   PubMed Web of Science ®Google Scholar
• VenturaCATommasiniSCrupiEChitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studiesEur J Pharm Biopharm200868223524417614266
   PubMed Web of Science ®Google Scholar
• ParkJHJinHEKimDDChungSJShimWSShimCKChitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalationInt J Pharm20134411–256256923142421
   PubMed Web of Science ®Google Scholar
• HwangSMKimDDChungSJShimCKDelivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosisJ Control Release2008129210010618538437
   PubMed Web of Science ®Google Scholar
• PalazzoFGiovagnoliSSchoubbenABlasiPRossiCRicciMDevelopment of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complexInt J Pharm2013440227328222659124
   PubMed Web of Science ®Google Scholar
• ChimoteGBanerjeeREvaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosisJ Biomed Mater Res A200989228129218431766
   PubMed Web of Science ®Google Scholar
• GangulySMoolchandaniVRocheJAPhospholipid-induced in vivo particle migration to enhance pulmonary depositionJ Aerosol Med Pulm Drug Deliv200821434335018823258
   PubMed Web of Science ®Google Scholar
• MansourHWangDSChenCSZografiGComparison of bilayer and monolayer properties and phospholipid systems containing dipalmitoylphosphatidyglycerol and dipalmitoylphosphatidylinositolLangmuir2001172166226632
   Web of Science ®Google Scholar
• MansourHMZografiGRelationships between equilibrium spreading pressure and phase equilibria of phospholipid bilayers and monolayers at the air–water interfaceLangmuir20072373809381917323986
   PubMed Web of Science ®Google Scholar
• MansourHMZografiGThe relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitionsJ Pharm Sci200796237739617080427
   PubMed Web of Science ®Google Scholar
• HickeyAJMansourHMFormulation challenges of powders for the delivery of small molecular weight molecules as aerosolsRathboneMJModified-Release Drug Delivery TechnologyNew York, NYInforma Healthcare2008573602
   Google Scholar
• HickeyAJMansourHMDelivery of drugs by the pulmonary routeFlorenceATSiepmannJModern PharmaceuticsNew York, NYTaylor and Francis2009191219
   Google Scholar
• HickeyAJMansourHMTelkoMJPhysical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristicsJ Pharm Sci20079651282130117455324
   PubMed Web of Science ®Google Scholar
• HickeyAJMansourHMTelkoMJPhysical characterization of component particles included in dry powder inhalers. II. Dynamic characteristicsJ Pharm Sci20079651302131917455364
   PubMed Web of Science ®Google Scholar
• SuarezSHickeyAJDrug properties affecting aerosol behaviorRespir Care200045665266610894458
   PubMedGoogle Scholar
• WuXLiXMansourHMSurface analytical techniques in solid-state particle characterization: implications for predicting performance in dry powder inhalersKONA Powder and Particle Journal201028319
   Google Scholar
• XuZMansourHMHickeyAJParticle interactions in dry powder inhaler unit processesJournal of Adhesion Science and Technology: Special Issue on Adhesion Aspects in Pharmaceutical Sciences2011254–5451482
   Google Scholar
• XuZMansourHMMulderTMcLeanRLangridgeJHickeyAJHeterogeneous particle deaggregation and its implication for therapeutic aerosol performanceJ Pharm Sci20109983442346120232454
   PubMed Web of Science ®Google Scholar
• AdiHTrainiDChanHKYoungPMThe influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulationsJ Pharm Sci20089772780278817894369
   PubMed Web of Science ®Google Scholar
• DunbarCAHickeyAJHolznerPDispersion and characterization of pharmaceutical dry powder aerosolsKONA Powder and Particle Journal199816745
   Google Scholar
• ZengXMMartinGPMarriottCParticulate Interactions in Dry Powder Formulation for Inhalation (Pharmaceutical Science Series)London, UKTaylor and Francis2001
   Google Scholar
• WuXZhangWHayesDJrMansourHMPhysicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol deliveryInt J Nanomedicine201381269128323569375
   PubMed Web of Science ®Google Scholar
• WuXHayesDJrZwischenbergerJBKuhnRJMansourHMDesign and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalationDrug Des Devel Ther201375972
   PubMed Web of Science ®Google Scholar
• MeenachSAVogtFGAndersonKWHiltJZMcGarryRCMansourHMDesign, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosolsInt J Nanomedicine2013827529323355776
   PubMed Web of Science ®Google Scholar
• LiXMansourHMPhysicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation deliveryAAPS PharmSciTech20111241420143022038473
   PubMed Web of Science ®Google Scholar
• LiXHayesDMansourHMTargeted lung delivery by inhalable multifunctional microparticulate/nanoparticulate aerosols for cystic fibrosis combination drug/mucolytic treatmentPediatr Pulmonol201134634622028276
   PubMed Web of Science ®Google Scholar
• ParkCWRheeYSVogtFGAdvances in microscopy and complementary imaging techniques to assess the fate of drugs ex vivo in respiratory drug delivery: an invited paperAdv Drug Deliv Rev201264434435621920394
   PubMed Web of Science ®Google Scholar
• MansourHMHickeyAJRaman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a reviewAAPS PharmSciTech200784E9918181559
   PubMed Web of Science ®Google Scholar
• Aerosols, nasal sprays, metered-dose inhalers, and dry powder inhalers monographUSP 29-NF 24: United States Pharmacopoeia and the National Formulary: The Official Compendia of Standards2924Rockville, MDUnited States Pharmacopeial Convention200626172636
   Google Scholar
• FinlayWHThe Mechanics of Inhaled Pharmaceutical Aerosols: An IntroductionLondon, UKAcademic Press2001
   Google Scholar
• FinlayWwebpage on the InternetARLA respiratory deposition calculatorEdmonton, ABAerosol Research Lab of Alberta2008 Available from: http://www.mece.ualberta.ca/arla/impactor_mmad_calculator.htmlAccessed June 20, 2010
   Google Scholar
• BrittainHGX-ray diffraction III: pharmaceutical applicationsSpectroscopy2001167
   Web of Science ®Google Scholar
• AlvesGPSantanaMHAPhospholipid dry powders produced by spray drying processing: structural, thermodynamic and physical propertiesPowder Technology20041452139148
   Web of Science ®Google Scholar